Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
4 Patents
#13 in Evry
#3,356 in France
Innavirvax
Forward Citations = 0
5 inventors:
Innavirvax
EPO Patents = 2
Forward Citations = 0
Loading Chart...
Loading Chart...
5 inventors (with patents filed for the assignee):
Patrice Debre (3 out of 8 patents)
Vincent Vieillard (3 out of 3 patents)
Joël Crouzet (1 out of 9 patents)
4. Raphaël Ho Tsong Fang (1 out of 1 patent)
5. Dominique Desfontaines (1 out of 1 patent)
6. Laurence Meyer (2 patents)
4 patents:
1. 10174080 - Compositions for preventing and/or treating an infection by an HIV-1 virus (2019-01-08),
Company Overview
Innavirvax is a biotechnology company focused on developing novel vaccines and therapeutics for infectious diseases. Our team of scientists and researchers are dedicated to advancing the field of immunology through innovative research and development. Our goal is to create safe and effective solutions to combat emerging and re-emerging infectious diseases, ultimately improving global health and well-being.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Innavirvax. Retrieved from https://idiyas.com/company/innavirvax
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]